ROIV Exercise Disclosure
Fitzgerald Meghan · SEC Form 4 · Filed Sep 10, 2026
Exercise
Calculated transaction value
$176K
Fitzgerald Meghan Director
ROIV
Roivant Sciences Ltd
ROIV
Transaction date
Sep 8, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 3 days later
ROIV daily price context
Close on/before transaction
$41.48
Sep 8, 2026
Close before public filing
$40.94
Sep 10, 2026
Return since public filing
+0.15%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 20,000 shares @ $8.8
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001140361-26-036246
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$974K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Roivant Sciences Ltd. ROIV | Sale | Sep 8, 2026 | $798K |
| Roivant Sciences Ltd. ROIV Current | Exercise | Sep 8, 2026 | $176K |
| Roivant Sciences Ltd. ROIV | Exercise | Sep 8, 2026 | $0 |